CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher

Data ReadoutPositive
AI Analysis

Summary

Moderna's stock climbs 6% as its cancer vaccine candidate continues a 137% monthly gain, with BioNTech and Novavax also posting gains.

Importance:3/10
Sentiment:
0.65
cancer_vaccinestock_movementModernaBioNTechNovavax
Related Companies

Read the original article

Published by yahoo_finance on September 17, 2026 1:50 PM

Read Original